Filter
58
Text search:
Sage
Working
Group
on
Vaccine
Hesitancy
Featured
Recommendations
3
New Publications
5
Language
Document type
Manuals
14
Studies & Reports
13
No document type
9
Guidelines
8
Strategic & Response Plan
7
Training Material
4
Fact sheets
2
Situation Updates
1
Countries / Regions
Global
6
Latin America and the Carribbean
5
Syria
3
Brazil
2
Sierra Leone
1
Congo, Democratic Republic of
1
Ghana
1
Pakistan
1
Afghanistan
1
Germany
1
Zambia
1
Bangladesh
1
Yemen
1
East and Southern Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Africa
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
18
Clinical Guidelines
14
Women & Child Health
8
Public Health
6
Toolboxes
COVID-19
31
Polio
3
Ebola & Marburg
2
TB
2
NTDs
2
Conflict
1
Refugee
1
Caregiver
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
2.0 Rapid Response
1
In its report from 2014, the Working Group outlines the various factors influencing vaccine acceptance or refusal, and what can be done to create s
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 202
...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Afric
...
WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on
...
This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can se
...
The authors state that researchers, governments and global agencies should proceed with particular care in the evaluation of candidate SARS-CoV-2 vaccines in LMICs, with effective communication to build trust and avoid generation of vaccine
...
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy
...
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
Data for Action March 2022, Issue 5
This guidance document provides basic broad principles for a spokesperson
of any health authority on how to respond to vocal vaccine deniers.
The suggestions are based
...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining
...
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use
...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Creat
...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (E
...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds
...
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
